By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates. The company has four programs in clinical trials, of which three of the programs are for the treatment of various cancers, and one for the treatment of Alpha-1 Antitrypsin Deficiency.

Contact Information

Website: www.inhibrx.com
Main Phone: +1 858 795-4220
Address: 11025 N. Torrey Pines Road
Address 2: Suite 200
State: CA
City / Town: La Jolla
Country: US
Postal Code: 92037

Issuer Information

Exchange: NSD
CEO: Mark P. Lappe
Employees: 91
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A